<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 30-Jul-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (30-Jul-2025)</h1>
<h2>Top News Highlights</h2>
<ul>
<li><strong>Large earthquake off Russia triggers Pacific tsunami:</strong>
<ul>
<li>Hawaii and California saw tsunami waves after an 8.7M quake off Russia; no major damage.</li>
</ul>
</li>
<li><strong>US tariffs on China bite global brands:</strong>
<ul>
<li>Adidas reports €200m in extra costs, plans price hikes.</li>
<li>Articles highlight rising US-China trade tensions and new tariff bands in place.</li>
</ul>
</li>
<li><strong>Fed rate decision and US GDP in focus:</strong>
<ul>
<li>Investors are awaiting the Fed’s next move; speculation leans toward no immediate rate change.</li>
</ul>
</li>
<li><strong>Eurozone growth underwhelms amid trade headwinds.</strong></li>
<li><strong>Massive bipartisan housing bill advances in Congress.</strong></li>
<li><strong>EPA signals potential reversal on climate regulation authority.</strong></li>
<li><strong>Novo Nordisk stock crashes on profit warning, weight-loss drug competition.</strong></li>
<li><strong>Middle East risks escalate:</strong>
<ul>
<li>UK to recognize Palestine unless Israel stops Gaza offensive.</li>
<li>Gaza death toll surpasses 60,000; famine warnings.</li>
</ul>
</li>
<li><strong>Thailand-Cambodia border truce holds after new clashes.</strong></li>
</ul>
<hr />
<h1>Macro &amp; Policy</h1>
<h2>Monetary Policy, Inflation &amp; Treasuries</h2>
<ul>
<li>
<p><strong>Fed Rate Outlook:</strong></p>
<ul>
<li>Market consensus has essentially priced out rate hikes or emergency cuts this year. A rate cut is widely expected, but any policy action looks likely to be modest (most likely scenario: one or two cuts by year-end).</li>
<li>Short-term: Fed policy is likely to remain a background support for risk assets but doesn't provide upside surprise. Any significant deviation (such as a surprise hike or no cuts at all) would be a volatility catalyst.</li>
</ul>
</li>
<li>
<p><strong>Inflation &amp; Yields:</strong></p>
<ul>
<li>Risks of inflation above target are stubbornly persistent, with a strong likelihood that CPI stays above 3% in 2025.</li>
<li>The 10-year Treasury is expected to remain elevated, with a substantial probability of yields exceeding 4.6%.</li>
<li><strong>Second-order effects:</strong> Higher for longer rates and sticky inflation place continued pressure on rate-sensitive sectors (real estate, mortgage-backed securities, longer-duration bonds), and support for commodities and value/cyclical stocks holds.</li>
<li>Bonds: Duration risk continues; rate volatility is likely if inflation disappoints to the upside.</li>
</ul>
</li>
<li>
<p><strong>US GDP/Employment:</strong></p>
<ul>
<li>A recession remains unlikely in 2025; economic growth forecast is for moderate 2.5-3.0% annualized pace.</li>
<li><strong>Equity implications:</strong> US equities should benefit from the resilient economy and “soft landing” narrative, with elevated multiples more sustainable if earnings hold up.</li>
</ul>
</li>
<li>
<p><strong>Fiscal Policy &amp; Debt:</strong></p>
<ul>
<li>US national debt will hit $38 trillion this year.</li>
<li>A government shutdown remains a pronounced risk (roughly 1-in-3 odds) as election rhetoric heats up and Congress wrestles with spending bills.</li>
<li><strong>Second-order effect:</strong> Political brinkmanship could temporarily spike Treasury volatility, creating tactical opportunities for cash/Bill rotation or for trading volatility instruments.</li>
</ul>
</li>
<li>
<p><strong>Trade Policy &amp; Tariffs:</strong></p>
<ul>
<li>High US tariffs on Chinese imports (25–40% range) are now the base case, driving up input costs for multinationals and adding to inflation.</li>
<li><strong>Second-order effects:</strong> Margins for consumer and industrial names with US China exposure face pressure. Companies with domestic or diversified supply chains (Mexico/India/ASEAN) likely benefit.</li>
<li><strong>Watch:</strong> Ongoing headlines about major brands (e.g., Adidas) raising prices in response to tariffs point to broader consumer inflation risk and margin headwinds for global multinationals.</li>
</ul>
</li>
</ul>
<hr />
<h1>Geopolitics &amp; Macro Risk</h1>
<h2>US/China</h2>
<ul>
<li>Little sign of tariff rollbacks this year—trade tensions remain a drag on select consumer and industrial segments.</li>
</ul>
<h2>Russia/Ukraine &amp; Europe</h2>
<ul>
<li>Hostilities continue, with further Russian gains in Ukraine probable before year-end. Major breakthroughs or NATO/EU engagement still seen as very remote risks.</li>
<li>Energy and grain markets remain exposed to Ukraine-Russia headlines, but the probability of a sharp escalation seems contained for now.</li>
<li>Political developments in France (likely PM reshuffle), Israel, and Russia are important but not immediately market-moving.</li>
</ul>
<h2>Middle East</h2>
<ul>
<li>UK poised to unilaterally recognize Palestinian statehood if an Israel-Hamas ceasefire isn’t achieved, raising the risk of diplomatic rifts with Washington.</li>
<li>Famine and high casualties in Gaza highlight continued instability; indirect market risk via energy supply shocks or headline-driven risk reversals.</li>
</ul>
<h2>Other</h2>
<ul>
<li>Thailand-Cambodia border skirmishes holding under truce; limited global market impact.</li>
</ul>
<hr />
<h1>Sector Themes</h1>
<h2>Technology &amp; AI</h2>
<ul>
<li>Near-universal expectation that OpenAI will open-source a new model soon, continuing the pace of innovation and commoditization in foundational AI.</li>
<li>Leadership shakeups or major competitive wins for challengers (Meta, Anthropic, Alibaba, Nvidia) are unlikely to disrupt the current AI stack.</li>
<li>Hardware providers and hyperscalers (chipmakers, datacenter REITs) maintain strong competitive moats; however, stock-specific risk remains high as hype matures.</li>
</ul>
<h2>Healthcare</h2>
<ul>
<li>Weight-loss drugmaker Novo Nordisk’s shock warning and stock rout underscores intensifying competition in GLP-1s and volatility for “miracle drug” narratives. Margin compression and sales risk are now very real for sector leaders.</li>
<li>US cannabis rescheduling remains unlikely this year; sector momentum and M&amp;A activity will reflect this regulatory inertia.</li>
</ul>
<h2>Energy &amp; Commodities</h2>
<ul>
<li>Persistent macro risks (Ukraine, Mideast, tariffs) support commodities/energy allocations.</li>
<li>ESG and decarbonization policy backdrop is shakier, with the EPA moving to pull back legal authority to regulate climate pollution. This weighs negatively on renewables and green tech, with legacy oil &amp; gas seeing relative support.</li>
</ul>
<h2>Housing</h2>
<ul>
<li>Massive bipartisan US housing bill suggests accelerated action on affordability and supply. Second-order impact: positive for residential construction, homebuilders, select REITs, but could curb rental REIT pricing power long term.</li>
</ul>
<hr />
<h1>Notable Individual Names &amp; Tickers</h1>
<ul>
<li><strong>Novo Nordisk</strong> (NVO): Faces margin and topline headwinds after profit warning. Watch competitors (LLY, PFE) for evidence of emerging GLP-1 commoditization.</li>
<li><strong>Adidas</strong> (ADDYY): Margin pressure and planned price hikes due to tariffs show consumer goods sensitivity to trade war; similar brands face ongoing headwinds.</li>
<li><strong>Meta/Facebook</strong> (META), Nvidia (NVDA): AI “top model” leadership remains elusive for both this year; focus shifts from hype to real-world adoption and monetization.</li>
<li><strong>SpaceX/Elon Musk names</strong>: Market expects record launch cadence for SpaceX, but little new market-moving risk on budget issues or program disruptions.</li>
<li><strong>Apple</strong> (AAPL): Routine update cycles; no significant catalysts from new OS releases.</li>
<li><strong>Major US Banks/Fed-sensitive Financials</strong>: Prepare for yield curve risk and margin compression if rates cut or rise unexpectedly.</li>
</ul>
<hr />
<h1>Tactical Takeaways</h1>
<ul>
<li>Portfolio positioning: Lean into US equity resilience, favor value/cyclicals versus high-multiple growth for now; maintain commodities/energy hedge; go underweight rate-sensitive fixed income until inflation and yield settles.</li>
<li>Watch for tactical volatility around:
<ul>
<li>Government shutdown/debt-ceiling negotiations,</li>
<li>Further upward inflation surprises,</li>
<li>Geopolitical flare-ups in the Middle East or Ukraine.</li>
</ul>
</li>
<li>Remain nimble on sector rotation driven by AI and healthcare narratives, but be wary of hype risk and regulatory swings.</li>
</ul>
<hr />
<p><strong>Summary:</strong><br />
Current data support a scenario of steady US economic growth, likely Fed accommodation with no sudden moves, persistent inflation risk, and continued global supply-chain and trade turbulence. Watch for sector-specific dislocations (healthcare, consumer discretionary, global brands) and remain alert for headline-driven volatility in rates and commodities.</p>

</main>
</body>
</html>
